Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
about
TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectionThe role of viral and bacterial pathogens in gastrointestinal cancer.Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells.Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptorLatent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsControl of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Latent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cellsMolecular virology of Epstein-Barr virus.Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceLymphomas differ in their dependence on Epstein-Barr virusEpstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo.Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.How human tumor viruses make use of autophagy.CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma.Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of OncogenesisExpression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized miceThe proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.Activation of the Notch-regulated transcription factor CBF1/RBP-Jkappa through the 13SE1A oncoprotein.
P2860
Q28361340-FE7D6694-04BD-4ABD-8A16-F04B8F4ECFB5Q33658144-1E866A39-56EC-4748-AC32-4856BBF11B5FQ33791751-94667E1C-D409-4087-AD4E-D8D4C286DC09Q33850400-EA63C1F9-0FEF-4EB0-825C-315A6ECD33ABQ33851043-89DBE966-8BC3-402D-9326-F5EF79DABC43Q33884691-3B6C29C7-0922-41DB-A846-FB6FE01D1056Q33887684-8EC1354D-DA26-4699-8B6D-B72ECECEE7E1Q33888498-720E04E7-8462-4B99-A7C2-CB0252661E18Q33891012-30712AF5-8AEB-43F4-8733-70100564B09FQ33898010-8A49B36D-0067-459B-9FE2-9DDDEEE5C200Q33918592-8B09F972-0B2F-4729-8996-846AD80146C7Q33996858-86102A90-8B69-4FDB-9B1F-311A4330D10FQ34178226-15535937-0F7F-4E2B-8B0D-61FC790F5DCFQ34225554-17257721-25E7-4802-A2A9-D8A99AB94F3BQ34250209-D5C69D4E-A1FB-4D7C-9462-62668FBC4C60Q34253049-FC47CD73-4AB1-4A97-9B36-C1F2FF25EF34Q34341875-F8753A00-2AC6-4F45-964B-4AAEA56ECDA1Q34667776-D21B3EAD-957A-443B-805E-A5D078D33368Q35024009-37C2B289-618D-4E83-AF01-49ABC3BF6064Q35147016-9EF04FA0-0AA3-4E02-83AE-8437DF476168Q35155237-38B085CE-B510-490C-B51B-ECC8391C13D1Q35848189-D4DB66E3-0BC1-46ED-8A91-1C6683CCD4C9Q36173276-F9DE03BA-E916-4D58-809A-547E030FC58FQ36498200-9302520B-5E4E-423B-9E58-3F7C5457D3ADQ36961875-B71E5729-F369-4614-9B08-C481A0960EEAQ37093792-E0A620F3-41D0-443A-8B09-07634F920677Q37512260-D3C1FB56-AF18-4E16-BD58-C3DB4839E590Q37641750-E3BABF22-1850-4E4D-A64D-F2342FDD570EQ37668114-CE89AF9D-0673-4F9E-8067-9324801A4E30Q38257974-ADC63171-03F4-4A6C-BBA4-CEDDE83F3E06Q38289967-90BD8B14-66A3-448B-ADF8-90889075360CQ38326876-D803FBC0-F339-4F25-A467-9BF40BF051AFQ39551287-F2518666-F6F1-4E37-A2E9-79C672D77504Q40423684-5D12C892-62A8-4A7C-8F23-9ED429044DF1
P2860
Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@ast
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@en
type
label
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@ast
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@en
prefLabel
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@ast
Epstein-Barr virus latent memb ...... 40 can prolong their survival.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus latent memb ...... D40 can prolong their survival
@en
P2093
C Van Kooten
G Marschall
G W Bornkamm
U Zimber-Strobl
W Hammerschmidt
P2860
P304
P356
10.1002/J.1460-2075.1996.TB01098.X
P407
P577
1996-12-01T00:00:00Z